Use of a new multiplex quantitative polymerase chain reaction based assay for simultaneous detection of Neisseria meningitidis, Escherichia coli K1 , Streptococcus agalactiae, and Streptococcus pneumoniae
- PMID: 34557274
- PMCID: PMC8421586
- DOI: 10.18502/ijm.v13i4.6970
Use of a new multiplex quantitative polymerase chain reaction based assay for simultaneous detection of Neisseria meningitidis, Escherichia coli K1 , Streptococcus agalactiae, and Streptococcus pneumoniae
Abstract
Background and objectives: Neisseria meningitidis, Escherichia coli K1, Streptococcus agalactiae, and Streptococcus pneumoniae cause 90% of bacterial meningitis. Almost all infected people die or have irreversible neurological complications. Therefore, it is essential to have a diagnostic kit with the ability to quickly detect these fatal infections.
Materials and methods: The project involved 212 patients from whom cerebrospinal fluid samples were obtained. After total genome extraction and performing multiplex quantitative polymerase chain reaction (qPCR), the presence or absence of each infectious factor was determined by comparing with standard strains.
Results: The specificity, sensitivity, positive predictive value, and negative predictive value calculated were 100%, 92.9%, 50%, and 100%, respectively. So, due to the high specificity and sensitivity of the designed primers, they can be used instead of bacterial culture that takes at least 24 to 48 hours.
Conclusion: The remarkable benefit of this method is associated with the speed (up to 3 hours) at which the procedure could be completed. It is also worth noting that this method can reduce the personnel unintentional errors which may occur in the laboratory. On the other hand, as this method simultaneously identifies four common factors that cause bacterial meningitis, it could be used as an auxiliary method diagnostic technique in laboratories particularly in cases of emergency medicine.
Keywords: Cerebrospinal fluid; Diagnosis testing; Meningitis; Quantitative polymerase chain reaction; Simultaneous detection.
Copyright © 2021 The Authors. Published by Tehran University of Medical Sciences.
References
-
- Tubiana S, Varon E, Biron C, Ploy MC, Mourvillier B, Taha MK, et al. Community-acquired bacterial meningitis in adults: in-hospital prognosis, long-term disability and determinants of outcome in a multicentre prospective cohort. Clin Microbiol Infect 2020;26: 1192–1200. - PubMed
-
- Principi N, Esposito S. Bacterial meningitis: new treatment options to reduce the risk of brain damage. Expert Opin Pharmacother 2020;21: 97–105. - PubMed
-
- Obaro S. Updating the diagnosis of bacterial meningitis. Lancet Infect Dis 2019;19: 1160–1161. - PubMed
-
- Kourna Hama M, Khan D, Laouali B, Okoi C, Yam A, Haladou M, et al. Pediatric bacterial meningitis surveillance in Niger: increased importance of Neisseria meningitidis serogroup C, and a decrease in Streptococcus pneumoniae following 13-valent pneumococcal conjugate vaccine introduction. Clin Infect Dis 2019;69(Suppl 2): S133–S139. - PMC - PubMed
-
- Jing-Zi P, Zheng-Xin H, Wei-Jun C, Yong-Qiang J. Detection of bacterial meningitis pathogens by PCR-Mass spectrometry in cerebrospinal fluid. Clin Lab 2018;64: 1013–1019. - PubMed
LinkOut - more resources
Full Text Sources